CME Group sets 2027 CFO, promotes new legal chief
CME Group details upcoming finance and legal leadership transitions, including a planned CFO succession and a new General Counsel.
Rhea-AI Filing Summary
CME Group Inc. (CME) announced a set of senior leadership changes in its finance and legal divisions. Jack Tobin, age 63, will be appointed Managing Director, Deputy Chief Financial Officer effective November 2, 2026, and is expected to become Chief Financial Officer in March 2027 when current President & CFO Lynne Fitzpatrick becomes CEO as previously disclosed. As CFO, Tobin will join the company’s management team.
Matthew Render, age 47, will succeed Tobin as Managing Director, Chief Accounting Officer effective November 2, 2026, after joining CME Group as Deputy Chief Accounting Officer in August 2026. The company states Render’s appointment is not pursuant to any arrangement with another person, there are no family relationships with directors or executives, and he has no material interests in related-party transactions requiring disclosure under Item 404(a) of Regulation S‑K. In the legal division, John Marchese will be promoted to General Counsel and join the management team later in September 2026, succeeding Jonathan Marcus, who is stepping down after serving as General Counsel since 2022.
Positive
- None.
Negative
- None.
Filing Explained
CME says Jack Tobin, previously set to retire on
8-K Event Classification
Key Figures
Key Terms
Chief Financial Officer financial
Chief Accounting Officer financial
General Counsel regulatory
management team financial
Item 404(a) of Regulation S-K regulatory
FAQ
What senior leadership changes did CME (CME) announce in this 8-K?
When will Jack Tobin become Chief Financial Officer of CME (CME)?
Who will be CME (CME) Chief Accounting Officer and when does it take effect?
What change is CME (CME) making in its General Counsel position?
Will Jack Tobin remain with CME (CME) despite previously announced retirement plans?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As described in the attached press release, CME Group Inc. (“CME Group” or the “Company”) announced new senior leadership appointments in its finance and legal divisions.
Jack Tobin, 63, will be appointed to the role of Managing Director, Deputy Chief Financial Officer as of November 2, 2026. Mr. Tobin has served as Managing Director and Chief Accounting Officer since 2015. He most recently served as Managing Director, Corporate Finance since 2007. Prior to our merger with CBOT Holdings, Mr. Tobin served as the Director, Corporate Finance for CBOT Holdings and CBOT from 2002 to 2007. Prior to joining CBOT, Mr. Tobin served as a principal consultant with PricewaterhouseCoopers from 1997 to 2002. Mr. Tobin is a registered certified public accountant.
Mr. Tobin will assume the role of Chief Financial Officer in March 2027, effective with Lynne Fitzpatrick’s transition to the role of Chief Executive Officer, as detailed in the Company’s Current Report on Form 8-K filed on June 17, 2026. As the Senior Managing Director, Chief Financial Officer, Mr. Tobin will be a member of the Company’s Management Team.
Matthew Render, 47, will succeed Mr. Tobin as the Company’s Managing Director, Chief Accounting Officer effective as of November 2, 2026. Mr. Render joined CME Group as the Managing Director, Deputy Chief Accounting Officer in August 2026. Prior to joining CME Group, Mr. Render was the Global Head of Financial Reporting, Accounting Policy & Finance Transformation at Citadel and Citadel Securities since 2018. Prior to that, Mr. Render held various accounting and financial roles at BP, including as Chief Financial Officer for BP, Cherry Point from 2016 to 2018, Head of Commodity Risk - Products from 2014 to 2016, Head of Accounting and Reporting for Global Oil Americas from 2013 to 2014 and Assistant Head of Accounting Policy, Integrated Supply and Trading from 2012 to 2013. Prior to that, Mr. Render was an assurance senior manager with Ernst & Young LLP from 2002 to 2012. Mr. Render is a registered certified public accountant. Mr. Render’s appointment as the Chief Accounting Officer was not pursuant to any arrangement or understanding between him and any other person. There are also no family relationships between Mr. Render and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Mr. Tobin and Mr. Render will participate in the Company’s compensation program on terms available to similarly situated executive officers of the Company.
As disclosed in the Company’s Current Report on Form 8-K filed on September 11, 2025, Mr. Tobin previously communicated his plans to retire from the organization effective as of October 30, 2026. In light of the aforementioned leadership changes, Mr. Tobin will continue his tenure with the Company.
Additional changes to the leadership structure are discussed in the attached press release.
Item 9.01. Financial Statements and Exhibits.
| Exhibit |
Description | |
| 99.1 | Press Release, dated September 9, 2026. | |
| 104 | The cover page from CME Group Inc.’s Current Report on Form 8-K, formatted in Inline XBRL. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CME Group Inc. | ||||||
| Registrant | ||||||
| Date: September 9, 2026 | By: | /s/ Lynne Fitzpatrick | ||||
| Name: | Lynne Fitzpatrick | |||||
| Title: | Senior Managing Director, President and Chief Financial Officer | |||||
| Principal Financial Officer and Duly Authorized Officer | ||||||
Exhibit 99.1
|
Media Contacts | Investor Contact | ||
| Laurie Bischel, 312.292.1937 | investors@cmegroup.com | |||
| news@cmegroup.com | CME-G | |||
| www.cmegroup.mediaroom.com |
FOR IMMEDIATE RELEASE
CME Group Announces New Senior Leadership Appointments
| • | Jack Tobin to Become Chief Financial Officer |
| • | John Marchese Named General Counsel |
| • | Matthew Render Appointed Chief Accounting Officer |
CHICAGO, September 9, 2026 – CME Group, the world’s leading derivatives marketplace, today announced senior leadership appointments in its finance and legal divisions.
Jack Tobin, who has served as CME Group Chief Accounting Officer since 2015, will be promoted to Chief Financial Officer and will join the company’s management team, effective March 2027, when the company’s current President & CFO Lynne Fitzpatrick becomes CEO as previously announced. To ensure a smooth transition, Tobin will become Deputy Chief Financial Officer in November 2026. Matthew Render will succeed Tobin as Chief Accounting Officer. Tobin will continue to report to Fitzpatrick, and Render will continue to report to Tobin.
In addition, John Marchese has been promoted to General Counsel, joining the CME Group management team and reporting to CME Group Chairman and Chief Executive Officer Terry Duffy. Marchese has been Managing Director & Associate General Counsel, Litigation & Information Technology since 2024. Later this month, he will succeed Jonathan Marcus, who is stepping down after serving as General Counsel since 2022.
“I want to congratulate Jack, John and Matt on their new roles that demonstrate the strong bench strength we have developed across our leadership team,” said Duffy. “I also want to thank Jonathan for his counsel to our company. Looking ahead, I am confident that these talented individuals will help CME Group continue to grow our global business in the years to come.”
Tobin has more than 35 years of financial experience, including overseeing accounting, corporate development and finance functions at CME Group since he joined the company in 2002. He previously worked as a principal consultant with PricewaterhouseCoopers and earned bachelor’s and master’s degrees from DePaul University.
Marchese joined CME Group in 2011 to lead the company’s litigation function after holding a number of leadership positions at Arthur Andersen LLP and Latham & Watkins. He earned a bachelor’s degree from Georgetown University and a J.D. from the University of Chicago.
Render joined CME Group as Deputy Chief Accounting Officer in August 2026. He previously held finance roles at Citadel, BP and Ernst & Young. He earned a bachelor’s degree from Northern Illinois University, a master’s degree from the University of Notre Dame and an MBA from the University of Chicago Booth School of Business.
As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.
# # #
26-88